Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,876 articles
Can AI Make Home Loans Cheaper? Palantir Thinks So
Palantir Technologies Inc. (NASDAQ:PLTR) and Moder on Thursday announced a strategic partnership to develop an AI-powered mortgage operations...
Super Micro Stock Sees Momentum Score Dip Despite Partner Nvidia's Launch Of New Blackwell AI Chips
Shares of Super Micro Computer Inc. (NASDAQ:SMCI) are facing a stark divergence between its operational milestones and its stock market performance...
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?
AbbVie stock sinks 5% as J&J's newly approved Icotyde raises competitive concerns for blockbuster Skyrizi in the fast-growing IL-23 market.
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?
AbbVie stock sinks 5% as J&J's newly approved Icotyde raises competitive concerns for blockbuster Skyrizi in the fast-growing IL-23 market.
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?
AbbVie stock sinks 5% as J&J's newly approved Icotyde raises competitive concerns for blockbuster Skyrizi in the fast-growing IL-23 market.
Why Are Micron Technology Shares Trading Lower On Thursday?
Micron Technology Inc (NASDAQ:MU) shares are down during pre-market trading on Thursday after the company delivered its second-quarter results on...
Castlemead Joins TechAssure's Select Global Network of Specialist Brokers
WASHINGTON, March 19, 2026 /PRNewswire/ -- TechAssure, the international network of insurance brokers specializing in complex and emerging risks, has...
📰
After the Viewbix-Quantum X Labs Closing: 5 Nasdaq Quantum Stocks to Watch
Moonage Media reviews the emerging quantum sector in the capital markets following Viewbix's acquisition of Quantum X Labs HONG KONG, March 19, 2026...
📰
Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia
DURHAM, N.C., March 19, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing...
📰
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
ASHBURN, Va., March 19, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical-stage...
📰
Sarepta pushes 2 Duchenne drugs toward traditional approval after mixed data - Stock Titan
Sarepta pushes 2 Duchenne drugs toward traditional approval after mixed data Stock Titan
Prologis and GIC Form $1.6 billion U.S. Build-to-Suit Logistics Joint Venture
Partnership to Fund Build-to-Suit Distribution Projects Across Major U.S. Markets SAN FRANCISCO and SINGAPORE, March 19, 2026 /PRNewswire/ --...
📰
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoing
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Organizational restructuring and cost reduction plan following results of the Phase 3 CYPRESS study of ampreloxetine are underway; expected to...
📰
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
Net proceeds from the offering will fund the commercialization of Symvess® in the vascular trauma indication and provide funding beyond key...
📰
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
<ul xmlns="http://www.w3.org/1999/xhtml" type="disc">
<li xmlns="http://www.w3.org/1999/xhtml"><i...
📰
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
📰
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
CAMBRIDGE, Mass., March 19, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today...
📰
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
Net proceeds from the offering will fund the commercialization of Symvess® in the vascular trauma indication and provide funding beyond key...
📰
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
110,064 Shares in Eli Lilly and Company $LLY Bought by CIBC Bancorp USA Inc.
CIBC Bancorp USA Inc. purchased a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) during the 3rd quarter, according to the company...
110,064 Shares in Eli Lilly and Company $LLY Bought by CIBC Bancorp USA Inc.
CIBC Bancorp USA Inc. purchased a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) during the 3rd quarter, according to the company...
110,064 Shares in Eli Lilly and Company $LLY Bought by CIBC Bancorp USA Inc.
CIBC Bancorp USA Inc. purchased a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) during the 3rd quarter, according to the company...
Accenture Stock Hits 52-Week Low - Here's Why
Accenture plc (NYSE:ACN) shares fell Thursday after the company's fiscal second-quarter 2026 results, as a cautious outlook overshadowed an...
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
📰
Aveanna Healthcare (AVAH) Beats Q4 Earnings and Revenue Estimates
Aveanna (AVAH) delivered earnings and revenue surprises of +38.78% and +5.64%, respectively, for the quarter ended December 2025. Do the numbers hold...
📰
Aveanna Healthcare (AVAH) Beats Q4 Earnings and Revenue Estimates
Aveanna (AVAH) delivered earnings and revenue surprises of +38.78% and +5.64%, respectively, for the quarter ended December 2025. Do the numbers hold...
CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
Upon the 2026 Stockholders' Meeting to be held in May 2026, subject to approval by the stockholders and board of directors of the Company, Corvex...
📰
CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
Upon the 2026 Stockholders' Meeting to be held in May 2026, subject to approval by the stockholders and board of directors of the Company, Corvex...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 36.7% to $1.75 during Thursday's pre-market session. The company's market...
Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the S&P 5000 futures falling around 0.1% on Thursday.
Shares of Alibaba Group Holding...
Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the S&P 5000 futures falling around 0.1% on Thursday.
Shares of Alibaba Group Holding...
Aerolínea brasileña GOL lanza venta de pasajes para vuelos intercontinentales directos entre Brasil y Portugal"
SÃO PAULO, 19 de marzo de 2026 /PRNewswire/ -- La aerolínea brasileña GOL Linhas Aéreas, que ahora inicia su fase intercontinental tras el reciente...